Parkinson's Disease (PD)
Parkinson's disease is a progressive neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra and accumulation of alpha-synuclein (Lewy bodies). The disease affects movement, autonomic function, cognition, and mood. Early diagnosis and multidisciplinary care improve quality of life.
Symptoms
Motor (TRAP)
- Tremor at rest (pill-rolling)
- Rigidity (cogwheel or lead-pipe)
- Akinesia/bradykinesia (slowed movement)
- Postural instability (falls)
Non-Motor
- Anosmia, REM sleep behavior disorder
- Constipation, urinary urgency, orthostatic hypotension
- Depression, anxiety, apathy
- Cognitive impairment, hallucinations (later stages)
- Pain, fatigue, weight loss
Diagnosis
- Clinical history and neurologic exam (asymmetry, response to levodopa)
- Supportive criteria: olfactory loss, autonomic symptoms, REM sleep behavior disorder
- DaTscan (dopamine transporter imaging) in atypical cases
- Rule out secondary causes (drug-induced, vascular, Wilson's disease)
Staging
- Hoehn and Yahr stages 1–5
- MDS-UPDRS (Unified Parkinson’s Disease Rating Scale) for detailed tracking
Treatment & Management
Medications
- Levodopa/carbidopa: gold standard; monitor for dyskinesias/motor fluctuations
- Dopamine agonists (pramipexole, ropinirole, rotigotine)
- MAO-B inhibitors (selegiline, rasagiline, safinamide)
- COMT inhibitors (entacapone, opicapone) to prolong levodopa effect
- Amantadine for dyskinesia
- Anticholinergics (trihexyphenidyl) in younger patients for tremor
Advanced Therapies
- Deep brain stimulation (DBS): subthalamic nucleus or globus pallidus for refractory motor symptoms
- Continuous levodopa intestinal gel or apomorphine infusion for severe fluctuations
Lifestyle & Rehabilitation
- Regular aerobic exercise, strength training, tai chi, boxing programs
- Physical therapy for gait/balance; occupational therapy for home adaptations
- Speech therapy (LSVT LOUD) for hypophonia/dysphagia
- Nutrition rich in fiber; timing protein away from levodopa doses
- Cognitive stimulation, counseling, social support
Non-Motor Symptom Management
- Manage depression/anxiety with SSRIs/SNRIs, CBT
- Treat REM sleep behavior disorder (melatonin, clonazepam)
- Autonomic dysfunction: hydration, compression stockings, midodrine/fludrocortisone for orthostasis
- Address hallucinations with pimavanserin or low-dose quetiapine/clozapine
Living with Parkinson's
- Maintain a medication schedule and track “on/off” periods
- Use fall-prevention strategies and adaptive devices
- Engage caregivers early; caregiver burnout is common
- Plan for driving evaluation, legal/financial decisions
Complications
- Motor fluctuations, dyskinesias
- Falls, fractures
- Aspiration pneumonia, swallowing difficulties
- Dementia, psychosis
- Impulse control disorders (dopamine agonists)
Research & Future Directions
Scientists explore disease-modifying therapies, gene therapy, stem cells, and digital biomarkers for early detection.
Experimental & Emerging Treatments
- Alpha-Synuclein Immunotherapies: Monoclonal antibodies (prasinezumab) aim to clear toxic aggregates.
- GLP-1 Agonists (exenatide, liraglutide): Repurposed diabetes drugs show neuroprotective signals.
- Gene Therapy (AAV vectors) delivering aromatic L-amino acid decarboxylase (AADC) or GAD to improve dopamine synthesis.
- Focused Ultrasound & Smart DBS: Adaptive DBS systems adjust stimulation automatically; focused ultrasound thalamotomy treats tremor without incisions.
Track Parkinson's with Diagnoza.care
Navigate Parkinson's Proactively – Log medications, motor/non-motor symptoms, “on/off” fluctuations, falls, therapies, and appointments, capture side effects, and let the AI companion highlight trends that signal medication or DBS adjustments.
Medical Disclaimer: Informational only. Work with your neurologist or movement disorder specialist to confirm diagnosis, optimize therapy, and evaluate surgical options.
Sources: Movement Disorder Society, American Academy of Neurology, Parkinson's Foundation